Spacelabs Healthcare Introduces New Multigas Module

Speed and Performance in a Small Package

ISSAQUAH, Wash.--(BUSINESS WIRE)-- Spacelabs Healthcare (www.spacelabshealthcare.com) is introducing a new Multigas Module that can identify and display agent values in less than 20 seconds, and is suitable for use on all patient populations – from newborn through adult – due to its low sample flow rate (50 ml/min). Capable of integrating directly into Spacelabs patient monitoring systems, the new Multigas Module incorporates advanced technology – including the PHASEIN gas analysis bench and NOMOLINE™ (no-moisture) gas sampling line – for increased performance and reliability in monitoring CO2, N2O, O2 and anesthetic agents.

“Spacelabs’ new Multigas Module provides clinicians with the information they need – quickly, accurately and reliably – to provide all of their patients, from infants to adults, with the very best patient care,” said Nicholas Ong, President of Spacelabs Healthcare.

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s Multigas Module. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.



CONTACT:

Spacelabs Healthcare, Inc.
Bruce Dammann, 425-657-7200 ext. 4005
[email protected]

KEYWORDS:   United States  North America  Washington

INDUSTRY KEYWORDS:   Health  Hospitals  Medical Devices  Other Health

MEDIA: